vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and CF BANKSHARES INC. (CFBK). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $15.7M, roughly 1.3× CF BANKSHARES INC.). CF BANKSHARES INC. runs the higher net margin — 40.0% vs -373.3%, a 413.4% gap on every dollar of revenue. CF BANKSHARES INC. produced more free cash flow last quarter ($18.2M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
CF Bankshares Inc. is a U.S.-based regional bank holding company operating through its community bank subsidiary. It offers a full suite of personal and commercial banking solutions including deposit products, various loan options, wealth management services and digital banking tools, primarily serving individual consumers and small-to-medium business clients across the U.S. Midwest region.
AUTL vs CFBK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $15.7M |
| Net Profit | $-79.1M | $5.7M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | 43.4% |
| Net Margin | -373.3% | 40.0% |
| Revenue YoY | — | 12.6% |
| Net Profit YoY | 3.6% | 29.9% |
| EPS (diluted) | $-0.30 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $15.7M | ||
| Q3 25 | $21.2M | $15.5M | ||
| Q2 25 | $20.9M | $15.6M | ||
| Q1 25 | $9.0M | $14.1M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | $0 | $13.1M | ||
| Q2 24 | $0 | $12.6M | ||
| Q1 24 | $10.1M | $12.2M |
| Q4 25 | — | $5.7M | ||
| Q3 25 | $-79.1M | $2.3M | ||
| Q2 25 | $-47.9M | $5.0M | ||
| Q1 25 | $-70.2M | $4.4M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-82.1M | $4.2M | ||
| Q2 24 | $-58.3M | $1.7M | ||
| Q1 24 | $-52.7M | $3.1M |
| Q4 25 | — | 43.4% | ||
| Q3 25 | -337.9% | 17.5% | ||
| Q2 25 | -292.6% | 41.1% | ||
| Q1 25 | -726.3% | 39.5% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | -384.1% | 30.9% |
| Q4 25 | — | 40.0% | ||
| Q3 25 | -373.3% | 15.1% | ||
| Q2 25 | -229.0% | 32.3% | ||
| Q1 25 | -781.1% | 31.4% | ||
| Q4 24 | — | 35.2% | ||
| Q3 24 | — | 32.2% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | -522.1% | 25.2% |
| Q4 25 | — | $0.88 | ||
| Q3 25 | $-0.30 | $0.36 | ||
| Q2 25 | $-0.18 | $0.77 | ||
| Q1 25 | $-0.26 | $0.68 | ||
| Q4 24 | — | $0.68 | ||
| Q3 24 | $-0.31 | $0.65 | ||
| Q2 24 | $-0.22 | $0.26 | ||
| Q1 24 | $-0.24 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $259.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $184.4M |
| Total Assets | $661.9M | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $259.0M | ||
| Q3 25 | $86.1M | $272.4M | ||
| Q2 25 | $123.8M | $275.7M | ||
| Q1 25 | $95.8M | $241.0M | ||
| Q4 24 | — | $235.3M | ||
| Q3 24 | $657.1M | $233.5M | ||
| Q2 24 | $705.9M | $241.8M | ||
| Q1 24 | $758.5M | $236.9M |
| Q4 25 | — | $184.4M | ||
| Q3 25 | $265.5M | $179.3M | ||
| Q2 25 | $346.5M | $177.0M | ||
| Q1 25 | $371.1M | $172.7M | ||
| Q4 24 | — | $168.4M | ||
| Q3 24 | $477.0M | $164.0M | ||
| Q2 24 | $527.8M | $159.6M | ||
| Q1 24 | $582.0M | $158.0M |
| Q4 25 | — | $2.1B | ||
| Q3 25 | $661.9M | $2.1B | ||
| Q2 25 | $721.0M | $2.1B | ||
| Q1 25 | $746.3M | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $827.5M | $2.1B | ||
| Q2 24 | $853.6M | $2.0B | ||
| Q1 24 | $901.4M | $2.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $18.7M |
| Free Cash FlowOCF − Capex | $-72.3M | $18.2M |
| FCF MarginFCF / Revenue | -341.2% | 115.6% |
| Capex IntensityCapex / Revenue | 20.8% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 3.26× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $33.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $18.7M | ||
| Q3 25 | $-67.9M | $5.5M | ||
| Q2 25 | $-72.8M | $8.0M | ||
| Q1 25 | $-75.6M | $2.2M | ||
| Q4 24 | — | $14.2M | ||
| Q3 24 | $-76.7M | $-1.3M | ||
| Q2 24 | $-51.1M | $4.0M | ||
| Q1 24 | $-40.5M | $-1.2M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | $-72.3M | $5.2M | ||
| Q2 25 | $-80.1M | $7.8M | ||
| Q1 25 | $-83.8M | $2.2M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | $-86.3M | $-1.3M | ||
| Q2 24 | $-51.9M | $4.0M | ||
| Q1 24 | $-41.0M | $-1.2M |
| Q4 25 | — | 115.6% | ||
| Q3 25 | -341.2% | 33.6% | ||
| Q2 25 | -382.6% | 50.3% | ||
| Q1 25 | -933.1% | 15.2% | ||
| Q4 24 | — | 99.6% | ||
| Q3 24 | — | -9.9% | ||
| Q2 24 | — | 31.6% | ||
| Q1 24 | -406.8% | -9.5% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 20.8% | 1.7% | ||
| Q2 25 | 34.8% | 0.7% | ||
| Q1 25 | 91.8% | 0.4% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 5.3% | 0.0% |
| Q4 25 | — | 3.26× | ||
| Q3 25 | — | 2.34× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 3.21× | ||
| Q3 24 | — | -0.30× | ||
| Q2 24 | — | 2.35× | ||
| Q1 24 | — | -0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
